Chemotherapy plus radiation improves survival in R1 NSCLC patients

US researchers have identified a survival benefit of postoperative combination chemotherapy and radiotherapy treatment in patients with non-small-cell lung cancer (NSCLC) who have microscopically positive surgical margins, regardless of pathological stage.

News Medical